Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citationAlon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604 · cited 1×
“However, it can cause blindness in premature newborns and in diabetic patient”
BackgroundDeterminants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Self-citationBiological Action of Leptin as an Angiogenic Factor
Sierra-Honigmann, M. R., Nath, A. K., Murakami, C., Garcı́a-Cardeña, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., et al. (1998) · Science · doi:10.1126/science.281.5383.1683 · Cited by 1,371 · cited 1×
“VEGF, bFGF (induced by insulin) and leptin (a central mediator in obesity) have been identified as mediators of angiogenesis in adipose tissu”
BackgroundHyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283 · cited 1×
“, whereas at the periphery, excess VEGF-C causes lymphatics to enlarg”
BackgroundSelf-citationCarmeliet, P., Lampugnani, M.-G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81010-7 · Cited by 1,283
Self-citationBenjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241 · cited 1×
“For example, they may lack functional perivascular cells, which are needed to protect vessels against changes in oxygen or hormonal balance, provide them necessary vasoactive control to accommodate metabolic needs, and induce vascular quiescenc”
BackgroundHypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Self-citationClinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Self-citationTumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 976 · cited 1×
“These include metabolic stress (for example, low p O 2 , low pH or hypoglycaemia), mechanical stress (for example, pressure generated by proliferating cells), immune/inflammatory response (for example, immune/inflammatory cells that have infiltrated the tissue), and genetic mutations (for example, activation of oncoge…”
BackgroundInflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946
Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
Solid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859 · cited 1×
“One explanation may be that neoplastic cells grown in a confined space generate mechanical stress, which may compress the newly formed lymphatic channels inside the tumou”
BackgroundSelf-citationHeymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P. M., Shipley, M., Angellilo, A., et al. (1999) · Nature Medicine · doi:10.1038/13459 · Cited by 794
Self-citationAngiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
Isner, J. M., & Asahara, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6889 · Cited by 770 · cited 1×
“Therapeutic perspectives: promises and problems Therapeutic angiogenesis Various angiogenic approaches to treat ischaemic diseases are already in clinical trial”
BackgroundDvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Baish, J. W., & Jain, R. K. (2000) · PubMed · Cited by 714
Self-citationCarmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
Self-citationAbsence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Self-citationEliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Pérez‐Atayde, A. R., Sallan, S. E., Tedrow, U. B., Connors, S. L., Allred, E. N., & Folkman, J. (1997) · Europe PMC (PubMed Central) · Cited by 553
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy, W. T., Richter, L., Frutiger, Y. M., & Grogan, T. M. (1999) · PubMed · Cited by 515
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510 · cited 1×
“It is now widely accepted that the ‘angiogenic switch’ is ‘off’ when the effect of pro-angiogenic molecules is balanced by that of anti-angiogenic molecules, and is ‘on’ when the net balance is tipped in favour of angiogenesi”
BackgroundTumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., & Thorpe, P. E. (1997) · Science · doi:10.1126/science.275.5299.547 · Cited by 477 · cited 1×
“It is possible that tumour vessels express surface proteins that are absent or barely detectable in mature vessel”
Background(2000) · PubMed · Cited by 475
Self-citationAlgire, G. H., Chalkley, H. W., Legallais, F. Y., & Park, H. D. (1945) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/6.1.73 · Cited by 472
Circulating endothelial precursors: mystery, reality, and promise
Rafii, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8774 · Cited by 432 · cited 1×
“Circulating endothelial precursors, shed from the vessel wall or mobilized from the bone marrow, can also contribute to tumour angiogenesi”
BackgroundTransformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
Flore, O., Rafii, S., Ely, S., O'Leary, J. J., Hyjek, E. M., & Cesarman, E. (1998) · Nature · doi:10.1038/29093 · Cited by 399 · cited 1×
“For instance, products of human herpesvirus-8 and human immunodeficiency virus type-1 (HIV-1) have been implicated in the pathogenesis of Kaposi's sarcoma, found in ∼30% of AIDS patient”
BackgroundPR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386
Self-citationQuantitative angiogenesis assays: Progress and problems
Jain, R. K., Schlenger, K., Hockel, M., & Yuan, F. (1997) · Nature Medicine · doi:10.1038/nm1197-1203 · Cited by 385
Self-citationAlbini, A., Soldi, R., Giunciuclio, D., Giraudo, E., Benelli, R., Primo, L., Noonan, D., Salio, M., Camussi, G., Rock, W., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1371 · Cited by 379 · cited 1×
“For instance, products of human herpesvirus-8 and human immunodeficiency virus type-1 (HIV-1) have been implicated in the pathogenesis of Kaposi's sarcoma, found in ∼30% of AIDS patient”
BackgroundJain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374 · cited 1×
“However, there is tremendous heterogeneity in leakiness over space and time and in response to treatmen”
BackgroundSelf-citationMolecular Mechanisms of Coronary Collateral Vessel Growth
Schaper, W., & Ito, W. D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.911 · Cited by 371
Leunig, M., Yuan, F., Menger, M. D., Boucher, Y., Goetz, A. E., Meßmer, K., & Jain, R. K. (1992) · PubMed · Cited by 370
Self-citationInvolvement of platelets in tumour angiogenesis?
Pinedo, H., Verheul, H., D'Amato, R., & Folkman, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05095-8 · Cited by 358
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/41.1.111 · Cited by 283
Patan, S., Munn, L. L., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0025 · Cited by 266 · cited 1×
“Subsequently, this primitive network expands by sprouting (angiogenesis) or intussusception, in which interstitial tissue columns are inserted into the lumen of pre-existing vessels and partition the vessel lume”
BackgroundSelf-citationEffect of host microenvironment on the microcirculation of human colon adenocarcinoma.
Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y., & Jain, R. K. (1997) · Europe PMC (PubMed Central) · Cited by 242
Self-citationModulation of the Organ Microenvironment for Treatment of Cancer Metastasis
Fidler, I. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1588 · Cited by 240
Ide, A. (1939) · American Journal of Roentgenology · Cited by 234
Genetic heterogeneity of angiogenesis in mice
Rohan, R. M., Fernandez, A., Udagawa, T., Yuan, J., & D'Amato, R. J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.871 · Cited by 214 · cited 1×
“Finally, the angiogenic response to various stimuli depends on the individual genetic constitution of experimental animal”
BackgroundStem cell therapy and gene transfer for regeneration
Asahara, T., Kalka, C., & Isner, J. M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301142 · Cited by 196
Goldmann, E. (1908) · PubMed · Cited by 180
Development and Disease in Proteinase-Deficient Mice
Carmeliet, P., & Collen, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00122-4 · Cited by 175
Self-citationHypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 172 · cited 1×
“In addition, hypoxia may select for clonal expansion of cells that have lost their apoptotic response to hypoxi”
BackgroundGohongi, T., Fukumura, D., Boucher, Y., Yun, C., Soff, G. A., Compton, C. C., Todoroki, T., & Jain, R. K. (1999) · Nature Medicine · doi:10.1038/13524 · Cited by 144
Self-citationAngiogenic activity of adipose tissue
Silverman, K., Lund, D. P., Zetter, B. R., Lainey, L. L., Shahood, J. A., Freiman, D. G., Folkman, J., & Barger, A. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81229-4 · Cited by 140 · cited 1×
“Indeed, preadipocytes migrate to sites of neovascularization and adipose tissue is highly angiogeni”
BackgroundMolecular Basis of Vascular Anomalies
Vikkula, M., Boon, L. M., Mulliken, J. B., & Olsen, B. R. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(98)00024-3 · Cited by 125 · cited 1×
“Vascular tumours (haemangiomas) in children are quite common and incapacitating, but we know little about their aetiolog”
BackgroundEhrmann, R. L., & Knoth, M. (1968) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/41.6.1329 · Cited by 118
Jain, R. K., & Munn, L. L. (2000) · Nature Medicine · doi:10.1038/72212 · Cited by 118
Self-citationChemotherapeutic drugs—more really is not better
Fidler, I. J., & Ellis, L. M. (2000) · Nature Medicine · doi:10.1038/74969 · Cited by 117
Boulton, A. J. M., & Malik, R. A. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70029-8 · Cited by 112
Leukocyte-endothelial adhesion and angiogenesis in tumors
Jain, R. K., Koenig, G. C., Dellian, M., Fukumura, D., Munn, L. L., & Melder, R. J. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437472 · Cited by 109
Self-citationGullino, P. M. (1978) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/61.3.639 · Cited by 109
Ramanujan, S., Koenig, G. C., Padera, T. P., Stoll, B. R., & Jain, R. K. (2000) · PubMed · Cited by 106
Self-citationTHE GROWTH OF MALIGNANT DISEASE IN MAN AND THE LOWER ANIMALS,
Goldmann, E. (1907) · The Lancet · doi:10.1016/s0140-6736(01)65002-5 · Cited by 86
Controlling the cellular brakes
Carmeliet, P. (1999) · Nature · doi:10.1038/44304 · Cited by 78
Self-citationHartford, A. C., Gohongi, T., Fukumura, D., & Jain, R. K. (2000) · PubMed · Cited by 66
Self-citationPulmonary hypertension: pathophysiology as a basis for clinical decision making
Rabinovitch, M. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00015-7 · Cited by 65 · cited 1×
“In chronic obstructive lung disease, hypoxia causes irreversible loss of vessels and thickening of the vascular muscular coat, with resultant life-threatening pulmonary hypertensio”
BackgroundPathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Self-citation
Research works printed but not linked: 7
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
“These newly characterized pathways have been functionally implicated in developmental and tumor-associated angiogenesis and illustrate the complex regulation of endothelial cell phenotypes (Pasquale, 2010; Ahmed and Bicknell, 2009; Dejana et al., 2009; Carmeliet and Jain, 2000).”
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
“With the identification of p63 and p73, p53 famly regulation of angiogenesis has broadened and become ore complex (Carmeliet & Jain, 2000).”
BackgroundPhotodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Self-citationNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Self-citationSkog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
“The tumour cells also hijack the normal vasculature and stimulate rapid formation of new blood vessels to supply nutrition to the tumou”
Background
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.